Blocking Na(+)/H(+) exchange reduces [Na(+)](i) and [Ca(2+)](i) load after ischemia and improves function in intact

J An1, S G Varadarajan, A Camara

  • 1Anesthesiology Research Laboratory, Department of Anesthesiology, The Medical College of Wisconsin, Milwaukee, 53226, USA.

Insights

Inhibiting sodium-hydrogen exchange (NHE) with benzamide (BIIB-513) in guinea pig hearts reduced intracellular sodium and calcium overload during ischemia and reperfusion. This intervention improved cardiac function and significantly reduced infarct size, highlighting NHE

Area of Science:

  • Cardiovascular Physiology
  • Cellular Electrophysiology
  • Pharmacology

Background:

  • Ischemia-reperfusion injury significantly impacts cardiac function and viability.
  • Intracellular ion overload, particularly sodium (Na+) and calcium (Ca2+), is implicated in reperfusion injury.
  • Sodium-hydrogen exchange (NHE) plays a critical role in regulating intracellular pH and Na+ balance.

Purpose of the Study:

  • To investigate the effect of NHE inhibition on intracellular Na+ and Ca2+ levels during ischemia and reperfusion in intact hearts.
  • To determine if NHE inhibition improves cardiac function and reduces infarct size following ischemia-reperfusion.
  • To assess the therapeutic potential of selective NHE-1 inhibitors like benzamide (BIIB-513).

Main Methods:

  • Isolated guinea pig hearts were subjected to 30 minutes of ischemia followed by reperfusion.
  • Selective NHE-1 inhibitor benzamide (BIIB-513) was administered either before ischemia or upon reperfusion.
  • Intracellular Na+ ([Na+]i) and Ca2+ ([Ca2+]i) concentrations were measured using fluorescence dyes.
  • Left ventricular pressure (LVP), ventricular fibrillation, and infarct size were assessed.

Main Results:

  • Benzamide (BIIB-513) significantly decreased peak increases in [Na+]i and [Ca2+]i during reperfusion.
  • Treatment with BIIB-513 improved systolic-diastolic LV pressure, cardiac efficiency, and oxygen consumption.
  • BIIB-513 reduced the incidence of ventricular fibrillation by 54% and decreased infarct size from 64% to 20%.

Conclusions:

  • Sodium loading is a key marker of reperfusion injury in intact hearts.
  • Inhibition of NHE effectively reduces Na+ and Ca2+ loading during reperfusion, thereby improving cardiac function.
  • Selective NHE inhibition offers a promising therapeutic strategy for mitigating ischemia-reperfusion injury in the heart.